In vitro Hemocompatibility Evaluation of the HeartWare Ventricular Assist Device Under Systemic, Pediatric and Pulmonary Support Conditions
- 7 July 2020
- journal article
- research article
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 67 (3) , 270-275
Abstract
The development of adult use right ventricular assist devices (RVADs) and pediatric left ventricular assist devices (pediatric LVADs) have significantly lagged behind compared to adult use left ventricular assist devices (LVADs). The HeartWare ventricular assist device (HVAD) intended to be used for adult’s systemic support, is increasingly used off-label for adult pulmonary and pediatric systemic support. Due to different hemodynamics and physiology, however, the HVAD’s hemocompatibility profiles can be drastically different when used in adult pulmonary circulation or in children, compared to its intended usage state, which could have a direct clinical and developmental relevance. Taking these considerations in mind, we sought to conduct in vitro hemocompatibility testing of HVAD in adult systemic, pediatric systemic and adult pulmonary support conditions. Two HVADs coupled to custom-built blood circulation loops were tested for 6 hours using bovine blood at 37°C under adult systemic, pediatric systemic, and adult pulmonary flow conditions (flow rate = 5.0, 2.5, and 4.5 L/min; differential pressure = 100, 69, and 20 mm Hg, respectively). Normalized index of hemolysis for adult systemic, pediatric systemic, and adult pulmonary conditions were 0.0083, 0.0039, and 0.0017 g/100 L, respectively. No significant difference was seen in platelet activation for these given conditions. High molecular weight von Willebrand factor multimer degradation was evident in all conditions (p < 0.05). In conclusion, alterations in the usage mode produce substantial differences in hemocompatibility of the HVAD. These findings would not only have clinical relevance but will also facilitate future adult use RVAD and pediatric LVAD development.Keywords
This publication has 36 references indexed in Scilit:
- Circulatory support devices: fundamental aspects and clinical management of bleeding and thrombosisJournal of Thrombosis and Haemostasis, 2015
- Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: Mechanical demolition and enzymatic cleavageThe Journal of Thoracic and Cardiovascular Surgery, 2015
- The CentriMag Centrifugal Blood Pump as a Benchmark for In Vitro Testing of Hemocompatibility in Implantable Ventricular Assist DevicesArtificial Organs, 2014
- Acquired von Willebrand Syndrome in Patients With a Centrifugal or Axial Continuous Flow Left Ventricular Assist DeviceJACC: Heart Failure, 2014
- In Vitro Shear Stress‐Induced Platelet Activation: Sensitivity of Human and Bovine BloodArtificial Organs, 2013
- HeartWare continuous-flow ventricular assist device thrombosis: The Bad Oeynhausen experienceThe Journal of Thoracic and Cardiovascular Surgery, 2012
- Biventricular support using implantable continuous-flow ventricular assist devicesThe Journal of Heart and Lung Transplantation, 2011
- First Experiences With the HeartWare Ventricular Assist System in ChildrenThe Annals of Thoracic Surgery, 2011
- Successful use of the HeartWare HVAD rotary blood pump for biventricular supportThe Journal of Thoracic and Cardiovascular Surgery, 2010
- A comparative study of common techniques used to measure haemolysis in stored red cell concentratesVox Sanguinis, 2010